CRPC samples exhibited significantly higher HoxB13 staining than ADPC or normal prostate samples (Figure1a,b), suggesting that HoxB13 expression increases during prostate cancer progression to the lethal phase. This evidence concerns the gene HOXB13 and prostate carcinoma.